ADC Linker

N3-PEG3-C2-NHS ester is a non-cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs), specifically facilitating the conjugation of biomolecules through versatile click chemistry approaches. This reagent features an azide group that enables copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing compounds, as well as strain-promoted alkyne-azide cycloaddition (SPAAC) with DBCO or BCN groups. Its unique characteristics make it an essential component for developing stable and effective ADCs in therapeutic research.

Boc-NH-C6-Br is a non-cleavable linker specifically designed for use in antibody-drug conjugates (ADCs). It facilitates the stable attachment of therapeutic agents to antibodies, enhancing the efficacy and specificity of targeted cancer therapies. Its robust chemical properties make it suitable for various applications in ADC development and research, enabling effective delivery of cytotoxic drugs to cancer cells.

Boc-Val-Cit-OH is a cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). This compound incorporates a valine-citrulline segment that allows for selective release of the attached drug in the target cells, enhancing therapeutic efficacy. Its application is pivotal in the development of ADCs that require controlled drug delivery mechanisms for targeted cancer therapy and other applications in drug discovery.

MC-Val-Ala-PAB-PNP is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This reagent facilitates the selective release of the cytotoxic drug component upon internalization and cleavage by specific enzymes within target cells. Its application is crucial in the development of targeted cancer therapies, enhancing the specificity and efficacy of drug delivery.

Dap-NE hydrochloride is a dipeptide hydrochloride that functions as a cleavable antibody-drug conjugate (ADC) linker. This reagent facilitates the conjugation of antibodies to cytotoxic agents, enabling the development of ADCs for targeted cancer therapies. It is valuable in research focused on therapeutic delivery systems and the optimization of ADC efficacy.

Mal-Bal-Ph(β-D-Glucose)-7-MAD-MDCPT is a versatile ADC linker that facilitates the synthesis of antibody-drug conjugates (ADCs). This compound is designed to provide stable and efficient coupling between antibodies and cytotoxic agents, enhancing targeted delivery in cancer therapeutics. Its unique structure allows for precise modulation of drug release, thereby improving efficacy in research applications related to drug development and bioconjugation techniques.

NH2-PEG4-CH2CH2COOH is a cleavable four-unit polyethylene glycol (PEG) linker designed for the synthesis of antibody-drug conjugates (ADCs) and PROTACs (proteolysis-targeting chimeras). This linker facilitates the conjugation of antibodies with cytotoxic agents, enhancing targeted drug delivery and therapeutic efficacy. Additionally, its application in PROTAC synthesis supports the development of innovative strategies for targeted protein degradation.

Azido-PEG7-amine is a non-cleavable 7-unit polyethylene glycol (PEG) linker designed for use in the synthesis of antibody-drug conjugates (ADCs) and PROTACs (Proteolysis Targeting Chimeras). This versatile linker features an azide functional group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with alkyne-containing molecules. Additionally, it can engage in strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing DBCO or BCN groups. Azido-PEG7-amine serves as an important tool for the development of advanced bioconjugates in chemical research.

Boc-NH-PEG4-CH2CH2COOH is a PEG-based linker designed for use in the synthesis of PROTACs (Proteolysis Targeting Chimeras), facilitating targeted degradation of specific proteins. Additionally, this compound serves as a cleavable linker for antibody-drug conjugates (ADCs), enhancing the delivery of therapeutic agents to specific cellular targets. Its versatile applications make it a valuable tool in chemical biology and drug development research.

DTSSP Crosslinker is a cleavable agent designed specifically for use in the synthesis of antibody-drug conjugates (ADCs). By forming stable covalent bonds between antibodies and cytotoxic drugs, it facilitates targeted delivery and enhances therapeutic efficacy. This linker is essential for research applications involving ADC development and optimization.

N-Boc-PEG4-bromide is a PEG-based linker that functions as a cleavable agent in antibody-drug conjugates (ADCs) and PROTACs. This compound facilitates the synthesis of PROTACs by providing a flexible and hydrophilic connector, enhancing solubility and biological activity. Its functional bromide group allows for effective conjugation to various biomolecules, making it a valuable tool in drug development research.

Mal-PEG3-NHS ester is a non-cleavable antibody-drug conjugate (ADC) linker that features a maleimide group for efficient covalent attachment to thiol-containing molecules. This compound facilitates the development of ADCs by enabling stable conjugation between antibodies and cytotoxic agents, enhancing targeted delivery in therapeutic applications. Mal-PEG3-NHS ester is particularly valuable in cancer research, as it supports the design of effective therapies that minimize off-target effects while maximizing tumor cell specificity.

Gly-Gly-Gly-PEG2-azide is an ADC linker that facilitates the synthesis of antibody-drug conjugates (ADCs). This reagent features an azide group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules. Additionally, it can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with DBCO or BCN-functionalized entities, making it a versatile tool for bioconjugation applications in chemical biology and therapeutic development.

Fluorescein-DBCO is a non-cleavable linker designed for use in the formation of antibody-drug conjugates (ADCs). This compound features a dibenzocyclooctyne (DBCO) group, enabling it to participate in strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with azide-containing molecules. Its unique properties make Fluorescein-DBCO an essential tool for researchers focusing on targeted drug delivery and cancer therapy applications through ADC development.

Fmoc-D-Trp(Boc)-OH is a cleavable linker used in the synthesis of antibody-drug conjugates (ADCs). This reagent facilitates the targeted delivery of cytotoxic agents by linking them to monoclonal antibodies, enhancing their therapeutic efficacy. It is particularly useful in studies focused on ADC design and development, enabling researchers to explore novel approaches to cancer treatment.

DBCO-Val-Cit-PABC-PNP is a cleavable linker designed for the construction of antibody-drug conjugates (ADCs). This compound features a DBCO moiety that participates in strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing substrates. Its unique structure enables precise conjugation and controlled release of cytotoxic agents, making it essential for advancing ADC research and therapeutic development.

Azido-PEG5-alcohol functions as a non-cleavable linker in the synthesis of antibody-drug conjugates (ADCs) and as a versatile PEG-based linker for PROTAC (proteolysis-targeting chimeras) development. It is characterized by its azide group, enabling copper-catalyzed azide-alkyne cycloaddition (CuAAc) and strain-promoted alkyne-azide cycloaddition (SPAAC) with alkyne, DBCO, or BCN-functionalized molecules. This reagent is instrumental in creating stable linkages for targeted protein degradation and therapeutic antibody conjugation, enhancing the efficacy of research applications in drug development.

N-Carbobenzoxy-L-homoserine is a derivative of L-homoserine modified with a carbobenzoxy protecting group, functioning as an effective linker for the synthesis of Antibody-Drug Conjugates (ADCs). This compound plays a crucial role in the development of targeted therapies by facilitating the conjugation of antibodies to cytotoxic agents, enhancing selectivity and potency in cancer treatment. Its utility extends to research applications focused on improving drug delivery systems in oncology.

Azido Myristic Acid is an azide compound that serves as a click chemistry reagent for probing post-translationally myristylated proteins. This reagent facilitates a straightforward two-step labeling and detection methodology, enabling researchers to investigate protein modifications efficiently. Azido Myristic Acid participates in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules and can also react via strain-promoted alkyne-azide cycloaddition (SPAAC) with dibenzocyclooctyne (DBCO) or bicyclononyne (BCN) derivatives, enhancing its versatility in bioconjugation applications.

Azido-PEG3-Val-Cit-PAB-PNP is a cleavable polyethylene glycol (PEG)-based linker designed for use in antibody-drug conjugates (ADCs) and PROTAC synthesis. This reagent features an azide functional group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) and strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with alkyne-containing molecules and those with DBCO or BCN groups, respectively. Its versatile application in bioconjugation and targeted therapies makes it a valuable tool for advancing chemical biology research.

Azido-PEG6-amine is a PEG-based PROTAC linker featuring an azide functional group, enabling copper-catalyzed azide-alkyne cycloaddition (CuAAc) and strain-promoted alkyne-azide cycloaddition (SPAAC) with alkyne-bearing and DBCO or BCN-containing molecules. This compound plays a crucial role in the synthesis of PROTACs, facilitating targeted protein degradation. Additionally, it serves as a non-cleavable linker in the development of antibody-drug conjugates (ADCs), providing significant versatility for researchers engaged in drug development and therapeutic applications.

Mal-L-PA-NH-Boc is a non-cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound facilitates stable attachment between the antibody and the cytotoxic payload, enhancing the therapeutic efficacy of ADCs. Its robust chemical properties make it suitable for various research applications in targeted cancer therapy and bioconjugation studies.

MC-Gly-Gly-Phe-Gly is a cleavable linker specifically designed for antibody-drug conjugates (ADCs). This compound facilitates the selective release of therapeutic agents upon internalization of the ADC, enhancing the targeted delivery of cytotoxic drugs to cancer cells. Its application in ADC development supports the design of more effective and targeted cancer therapies.

Bis-PEG3-NHS ester is a non-cleavable linker that features a three-unit polyethylene glycol (PEG) structure, designed for use in the construction of PROTACs (proteolysis-targeting chimeras). This reagent facilitates the effective conjugation of antibodies to various agents, enhancing their therapeutic potential. Its unique properties make it suitable for applications in targeted drug delivery and protein degradation studies.

Sulfo-SPDB is a cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). It facilitates the selective release of cytotoxic agents in targeted cancer therapies, enhancing the efficacy and precision of treatment. Sulfo-SPDB is valuable in research applications focusing on ADC development, providing a critical component in the creation of advanced therapeutic agents.

DBCO-PEG2-NHS ester is a click chemistry reagent with an azide group, designed to facilitate bioconjugation through reactions with primary amines, such as lysine side chains or aminosilane-coated surfaces. This PEG-based compound features an NHS ester, which enables the formation of stable covalent bonds under neutral to slightly basic conditions. The hydrophilic polyethylene glycol (PEG) spacer enhances solubility and adds flexibility, reducing steric hindrance during ligation. DBCO-PEG2-NHS ester is ideal for applications in copper-free Click Chemistry and other bioconjugation studies.

Val-Ala-PAB is a cleavable ADC linker that facilitates the synthesis of antibody-drug conjugates (ADCs). This linker is designed to enhance the stability and efficacy of ADCs by enabling controlled release of the cytotoxic payload upon internalization. It is particularly useful in cancer research applications where targeted delivery of therapeutics is paramount.

Fomc-Gly-Gly-Phe-Gly-OH functions as an ADC linker, facilitating the synthesis of advanced antibody-drug conjugates. This compound serves as a key intermediate, leading to the formation of the dual-drug linker GGFGE, which is essential for creating complex ADC assemblies. Its use is pivotal in the development of targeted therapies, enhancing the efficacy of cancer treatments through specific drug delivery mechanisms.

N-Boc-PEG2-bromide is a cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs) and PROTACs. Its PEG-based structure facilitates enhanced solubility and flexibility, contributing to improved therapeutic efficacy. This reagent is essential for researchers focused on developing targeted drug delivery systems and studying protein degradation pathways.

Fmoc-NH-PEG2-CH2CH2COOH is a cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs). This PEG-based linker enables efficient conjugation and release of the active drug following target engagement. Additionally, Fmoc-NH-PEG2-CH2CH2COOH can be employed in the development of PROTACs for targeted protein degradation studies, facilitating advances in therapeutic applications and research in cancer biology.

Boc-Hyp-OH is a non-cleavable linker primarily utilized in the synthesis of antibody-drug conjugates (ADCs). This compound serves as an alkyl chain-based PROTAC linker, enabling the development of proteolysis-targeting chimeras (PROTACs). Its stability and compatibility make Boc-Hyp-OH ideal for applications in targeted cancer therapies and drug development research.

Fmoc-NH-PEG6-CH2CH2COOH is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). It facilitates the conjugation of therapeutic agents to antibodies, enabling targeted drug delivery while maintaining the stability of the conjugate in circulation. This compound is valuable in research applications focused on developing effective ADCs for cancer therapy and other diseases.

NH2-PEG2-C2-Boc is a PEG-based linker designed for use in the synthesis of PROTACs and antibody-drug conjugates (ADCs). This non-cleavable linker comprises two PEG units, facilitating efficient conjugation while ensuring stability in biological systems. Its application is crucial in the development of targeted therapeutics, enabling precise modulation of protein degradation and enhancing the efficacy of ADCs in research and therapeutic contexts.

DBCO-CONH-S-S-NHS ester is a cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). Its primary mechanism involves the DBCO group, facilitating strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules. This reagent plays a crucial role in the development of ADCs, allowing for targeted delivery of cytotoxic agents and enhancing therapeutic efficacy. Suitable for various applications in chemical biology and bioconjugation research.

Bis-PEG2-NHS ester is a non-cleavable linker that facilitates the conjugation of antibodies to drug agents in antibody-drug conjugates (ADCs). This 2-unit PEG linker enhances the solubility and stability of the conjugate while maintaining the biological activity of the antibodies. It is particularly useful in targeted therapy research and development, enabling precise delivery of cytotoxic agents to tumor cells.

Mal-PEG1-NHS ester is a non-cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs). This PEG-based compound facilitates the formation of stable conjugates, enhancing target specificity and therapeutic efficacy. It is also applicable in the synthesis of PROTACs, providing valuable utilities in drug discovery and development for targeted protein degradation.

Fmoc-NH-PEG3-CH2CH2COOH is a cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs). This PEG-based linker facilitates targeted drug delivery by coupling therapeutic agents to antibodies, enhancing specificity and efficacy. In addition, it serves as a useful component in the development of PROTACs (proteolysis-targeting chimeras), enabling the targeted degradation of specific proteins in various research applications.

Eicosanedioic acid is a non-cleavable linker employed in the construction of antibody-drug conjugates (ADCs). This alkyl chain-based linker is also utilized in the development of proteolysis-targeting chimeras (PROTACs), facilitating targeted protein degradation. Its unique properties enhance the stability and efficacy of therapeutic compounds in various biomedical research applications.

N3-C2-NHS ester is a non-cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). This compound features an azide group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with alkyne-containing molecules, as well as strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with DBCO or BCN groups. Its robust reactivity makes it an essential tool in the development of targeted therapeutic agents in chemical and bioconjugation research.

Propargyl-PEG2-amine is a non-cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). As a PEG-based PROTAC linker, it is suitable for creating various PROTACs in chemical research. This compound features an alkyne group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc), making it a valuable click chemistry reagent for molecular conjugation applications.

H-Gly-Gly-Phe-OH is a tripeptide linker primarily utilized in the synthesis of antibody-drug conjugates (ADCs). The N-terminal glycine residue provides a reactive site that enables various coupling reactions with carboxylic acids or NHS esters. This compound is essential for the development of targeted therapies, allowing for the precise delivery of cytotoxic agents to specific cells. Its versatility makes it a valuable tool in pharmaceutical research and development.

Cyclooctyne-O-NHS ester is a versatile ADC linker utilized in the synthesis of antibody-drug conjugates (ADCs). This compound features an alkyne group, allowing for efficient click chemistry applications, specifically through copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing molecules. Its reactivity and cleavable nature make it an essential tool for developing targeted therapies in chemical biology and drug development.

Tetrazine-biotin is a cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs). This compound features a tetrazine moiety that participates in the inverse electron demand Diels-Alder (iEDDA) reaction with TCO-containing molecules, facilitating efficient click chemistry. Tetrazine-biotin is a valuable tool for researchers exploring targeted drug delivery and the development of novel ADC therapies.

m-PEG3-Amine is a PEG-based linker designed for use in antibody-drug conjugates (ADCs) and PROTAC synthesis. This cleavable linker facilitates the efficient delivery of therapeutic agents, enhancing the pharmacological properties of the conjugates. It is ideal for research applications focused on targeted therapy and the development of novel drug delivery systems.

m-PEG5-CH2COOH is a non-cleavable linker designed for use in antibody-drug conjugates (ADCs) and PEG-based PROTACs. It facilitates the synthesis of ADCs by enabling stable connectivity between the antibody and the cytotoxic drug. Additionally, m-PEG5-CH2COOH serves as an effective linker for the development of PROTACs, thereby supporting targeted protein degradation research. Its chemical properties enhance the overall efficacy and stability of conjugated compounds in biological applications.

Biotin-PEG3-SS-azide is a cleavable linker designed for antibody-drug conjugates (ADCs), featuring a three-unit polyethylene glycol (PEG) moiety. This reagent contains an azide functional group, enabling copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules. Additionally, it is capable of participating in strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules that possess DBCO or BCN groups, making it a versatile tool for bioconjugation in chemical biology and therapeutic development.

1-N-Boc-3-hydroxyazetidine is a non-cleavable linker primarily utilized in the fabrication of antibody-drug conjugates (ADCs). This compound facilitates the stable attachment of therapeutic agents to antibodies, enhancing targeted delivery in cancer treatment. Additionally, it serves as an alkyl chain-based linker in the development of PROTACs (proteolysis-targeting chimeras), making it beneficial for studies involving targeted protein degradation and therapeutic development in various diseases.

3-Azidopropanol is an azide-containing alcohol utilized as a substrate in click chemistry reactions. It facilitates Cu-catalyzed addition reactions with propargyl alcohol, making it a valuable tool in bioconjugation and labeling strategies. This reagent is essential for applications in biochemical assays, enabling the study of biomolecular interactions and the development of targeted therapeutics.

Mal-PEG4-Val-Cit-PAB-PNP is a cleavable linker designed for use in antibody-drug conjugates (ADCs). This 4 unit PEG-based molecule facilitates the attachment of cytotoxic agents to antibodies, promoting targeted delivery and enhanced therapeutic efficacy. Its distinctive structure allows for controlled release of the drug upon cleavage, making it a valuable tool in cancer research and drug development.

BCN-PEG3-Biotin is a non-cleavable three-unit polyethylene glycol (PEG) linker specifically designed for use in antibody-drug conjugates (ADCs). This reagent features a bicyclo[6.1.0]nonyne (BCN) group that facilitates strain-promoted azide-alkyne cycloaddition (SPAAC) with azide-containing molecules. It serves as a valuable tool in the synthesis of ADCs, enhancing stability while providing biotin functionality for further bioconjugation applications in research and development.